<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<TITLE>PNI.org | Pacific Neuropsychiatric Institute</TITLE>
 
<META NAME="description" CONTENT="The Pacific Neuropsychiatric Institute
(PNI) is involved with comprehensive evaluation and management in
Neuropsychiatry and Psychopharmacology at the clinical, research,
forensic, education and phenomenologic levels.">
<META NAME="keywords" CONTENT="Vernon Neppe, medicine, psychopharmacology,
neuropsychiatry, forensic psychiatry, neuropsychiatric, institute,
education, lectures, brain, forensics, journal, internet journal, Neppe,
neurotransmitters, medical ethics, questionnaire, research instruments,
caffeine, philosophy, vortex pluralism, epileptology, anomalous, informed
consent, pharmacology, neuropsychology, clinical medicine, mental health,
brain injury, epilepsy, seizure, head injury, deja vu, anomalistic
experience, parapsychology, phenomenology, psychiatric, medical, drug,
BROCAS SCAN, STRAW, INSET, NMBPRS, PBRS, mental status, MMPI, SCL-90,
MMSE, Electroencephalogram, Electroencephalography, EEG, Ambulatory
monitoring, Ambulatory EEG, ventricular dilatation, MRI head, CT head,
SPECT head, PET head, competency, statistics, litigation, competence,
deposition, evidence, ethics, pharmacokinetics, pharmacodynamics, P450,
side-effects, tachyphylaxis, FDA, in vitro, in vivo, receptorology, civil
litigation, DSM, internet journal of Neuropsychiatry and
Psychopharmacology, JINEPP, INEPP, medical books, innovative
psychopharmacotherapy, partial agonist, agonist, antagonist, receptor,
synapse, autoreceptor, post-synaptic, pre-synaptic, down regulation, up
regulation, supersensitivity, subsensitivity, GABA, NMDA, receptor
subtypes, serotonin, norepinephrine, acetylcholine, benzodiazepine,
dopamine, opiates, chloride ionophore, pituitary, hypothalamus, temporal
lobe, frontal lobe, parietal lobe, occipital lobe, cerebral cortex,
kindling, chindling, bathtub, pushbuttons, motivation, MSE, mental status
examination, cognition, affect, volition, lesion localization,
psychomotor, dangerousness, environmental interaction, memory,
concentration, normality, organic brain syndrome, behavioral neurologist,
sleep, obesity, bariatric medicine, EMG, Electromyography, Nerve
conduction, antidepressant, anxiolytic, anxioselectivity, psychostimulant,
beta blocker, beta blockade, anticonvulsant, adjunctive therapy, appetite
suppressants, computer therapy, computerized diagnosis, memory retraining,
speech retraining, neuropharmacology, neuropharmacologist,
psychopharmacology, psychopharmacologist, anxiety, depression, OCD, ADD,
ADHD, attention deficit hyperactivity disorder, aggression, irritability,
tardive dyskinesia, movement disorder, neurology, Parkinson's, headache,
pain, sexual dysfunction, fibromyalgia, obsessive compulsive, Alzheimer's,
seizure, epilepsy, epileptic, TLE, CPS, closed head injury, CHIT, CHIP,
MTBI, PTSD, traumatic brain injury, methylphenidate, Ritalin, zolpidem,
Ambien, nadolol, Corgard, pemoline, Cylert, selegeline, nitrous oxide,
azapirones, phenytoin, Dilantin, topiramate, Topamax, tiagabine, Gabitril,
valproate, Depakote, felbamate, Felbatol, gabapentin, Neurontin,
carbamazepine, Tegretol, lamotrigine, Lamictal, neuroleptics, sumatriptan,
Imitrex, Sinemet, carbidopa, SSRI, sertraline, paroxetine, fluvoxamine,
fluoxetine, Zoloft, Paxil, Prozac, Luvox, bupropion, Wellbutrin, tricyclic
antidepressant, amitriptyline, imipramine, bromocriptine, Eldepryl,
Aricept, donepezil, pergolide, Cognex, tacrine, Parlodel, cyclobenzaprine,
Flexeril, phentermine, Buspar, buspirone, nefazodone, Serzone,
venlafaxine, Effexor, clozapine, Clozaril, perphenazine, Trilafon,
mirtazapine, Remeron, recreational drugs, firearms, cigarette, marijuana,
cannabinol, herbal remedies, St John's Wort, anti-oxidant,
proanthocyanadin, vitamin, mineral, melatonin, herbal, cannabis, tea,
coffee, cola drinks, pyridoxine, vitamin, mineral, ascorbic acid,
ascorbate, B6, anxiety, neurosis, depression, post-traumatic stress
disorder, Alzheimer's, dementia, cognitive deterioration, premenstrual
syndrome, PMS, panic, eating disorders, migraine, schizophrenia, bipolar
illness, manic, depression, mania, temporal lobe dysfunction, phobia,
pervasive developmental disorder, PDD, autism, obsessive compulsive
disordor, psychosis, refractory conditions, narcolepsy, drug abuse,
alcoholism, extrasensory perception, ESP, delta, psi, afferent, efferent,
subjective, vortex, paranormal, psychic, psychokinesis, PK, out of body
experience, OOBE, OBE, near death experience, NDE, survival, veridical,
dream, telepathy, clairvoyance, precognition, retrocognition, mediumship,
ectoplasm, aura, psychometry, remote viewing, Ganzfeld, deja entendu,
geomagnetic, deja pense, deja senti, deja pressenti, anomalous,
spontaneous, reincarnation, forced choice, Zener cards, experient,
non-experient, altered state, consciousness, phenomenologic">

<LINK REL="stylesheet" TYPE="text/css" HREF="http://www.pni.org/styles.css">

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">

<script language="JavaScript" type="text/JavaScript">
<!--
function MM_displayStatusMsg(msgStr) { //v1.0
  status=msgStr;
  document.MM_returnValue = true;
}
//-->
</script>

</head>

<body text="#000000" link="#990000" vlink="#990000" alink="#990000" onLoad="MM_displayStatusMsg('PNI.org | Pacific Neuropsychiatric Institute');return document.MM_returnValue">
<a name="top"></a> 
<table width="700" border="1" align="center" cellpadding="0" cellspacing="0" bordercolor="#000000">
  <tr> 
    <td><table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="C4D2FF">
        <tr> 
          <td><a href="/"><img src="../header.jpg" width="700" height="127" border="0"></a></td>
        </tr>
        <tr>
          <td>
		  <div align="right">
				<a href="http://brainvoyage.com/">www.brainvoyage.com</a>
				 | <a href="http://vernonneppe.org/">www.vernonneppe.org</a>
				 | <a href="http://vernonneppe.com/">www.vernonneppe.com</a>
				 | <a href="http://ecao.us/">www.ecao.us</a>&nbsp;
			</div>
			<div align="left" >
				<script>
				  (function() {
					var cx = '009175660163571863627:du9tocqgd6q';
					var gcse = document.createElement('script');
					gcse.type = 'text/javascript';
					gcse.async = true;
					gcse.src = 'https://cse.google.com/cse.js?cx=' + cx;
					var s = document.getElementsByTagName('script')[0];
					
					s.parentNode.insertBefore(gcse, s);
				  })();
				</script>
				<gcse:search></gcse:search>
			</div>
			<table width="100%" border="0" cellspacing="0" cellpadding="15">
              <tr>
                <td width="100%"><p><font size="3" face="Arial, Helvetica, sans-serif"><strong>
                    <a href="http://pni.org/neuropsychiatry/">NEUROPSYCHIATRY and BEHAVIORAL NEUROLOGY</a>
                     | 
                    <a href="http://pni.org/psychopharmacology/">PSYCHOPHARMACOLOGY</a><br><a href="http://pni.org/forensics/">FORENSICS</a> | <a href="/research/">RESEARCH</a>
					 | 
                    <a href="http://pni.org/consciousness/">CONSCIOUSNESS</a>
					 | 
                    <a href="http://pni.org/philosophy/">PHILOSOPHY</a> | <a href="http://www.brainvoyage.com/ctbm/">BOOKS</a> | <a href="/books/">LITERATURE</a><br>
                    <a href="http://pni.org/perspective.html">PERSPECTIVES</a>
                    | <a href="http://pni.org/clinical/">CLINICAL</a> | <a href="http://pni.org/research/anomalous/deja/">D&Eacute;J&Agrave; VU</a> | 
                    <a href="http://pni.org/interesting/">INTERESTING AREAS</a> | <a href="http://pni.org/philosophy/ethics/">ETHICS</a>
                    | <a href="http://pni.org/about_pni.html">CONTACT</a></strong></font></p>
                <p>
					<strong>
						KEY ARTICLES:
						<a href="http://www.pni.org/neuropsychiatry/consciousness/">CONSCIOUSNESS</a> | 
						<a href="http://pni.org/key-articles/double-blind.html">DOUBLE BLIND</a> | 
						<a href="http://pni.org/neuropsychiatry/chit/">HEAD INJURY</a> | 
						<a href="http://pni.org/neuropsychiatry/narcolepsy/">NARCOLEPSY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/paroxysmal/">PAROXYSMAL DISORDERS</a> | 
						<a href="http://pni.org/psychopharmacology/principles/">PRESCRIPTION PRINCIPLES</a> | 
						<a href="http://www.pni.org/neuropsychiatry/tardive_dyskinesia/">TARDIVE DYSKINESIA</a> |
						<a href="http://www.pni.org/neuropsychiatry/moral_philosophy/">MORAL PHILOSOPHY</a>
						</strong>
						<p>
					<strong>
						Enduring Interest: </strong>
						<a href="http://www.pni.org/psychopharmacology/generics">Generic Substitution</a> | 
						<a href="http://www.pni.org/intelligence/">Genius</a> | 
						<a href="http://www.pni.org/groundbreaking/">Groundbreaking Paradigm Shifts</a> | 
						<a href="http://www.pni.org/ethics/security/">Zmail</a> |
						<a href="http://www.pni.org/philosophy/">Philosophy</a>
					
				</td>
              </tr>
            </table>
            <table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tr> 
                <td class="bodyText" valign="top">                  <table width="650" border="0" align="center" cellpadding="5" cellspacing="0">
                    <tr> 
                      <td width="74%" valign="top"> <H1>Neppe D&eacute;j&agrave; 
                          Vu Research and Theory </H1>
                        <H2>Table of Contents</H2>
                        <TABLE BORDER=0 CELLSPACING=5>
                          <TR> 
                            <TD> <LI><A HREF="#overview">Overview of Neppe Research</A> 
                              <LI><A HREF="#concept">Concept of D&eacute;j&agrave; 
                                Vu</A> 
                              <LI><A HREF="#incidence">Incidence of D&eacute;j&agrave; 
                                Vu</A> </TD>
                            <TD> <LI><A HREF="#ages">Ages of D&eacute;j&agrave; 
                                Vu</A> 
                              <LI><A HREF="#causes">Causes of D&eacute;j&agrave; 
                                Vu</A> 
                              <LI><A HREF="#is deja vu a symptom"> Is D&eacute;j&agrave; 
                                Vu A Symptom of Temporal Lobe Epilepsy?</A> 
                              <LI><A HREF="#references">References</A> </TD>
                          </TR>
                        </TABLE>
                        <P> See also the <A HREF="../neuropsychiatry/instruments/deja_vu.html"> 
                          D&eacute;j&agrave; Vu Questionnaire</A> and <A HREF="./#the psychology of d&eacute;j&agrave; vu"> 
                          The Psychology of D&eacute;j&agrave; Vu</A>. </P>
                        <!--
<A NAME="background"></A>
<H3>Background:</H3> 
<P>
This book is the only one on the d&eacute;j&agrave; vu phenomenon. 
It is unfortunately not in press anymore and because of the 
limited first edition and a publication spine error it is a 
potential valuable collectors item. At this point remaining 
copies are not even for sale. Contact deja@pniorg for details.
</P>
-->
                        <A NAME="overview"></A> <H3> Overview of Neppe Research: 
                          Different Presentations of D&eacute;j&agrave; Vu: </H3>
                        <P> This study shows there are at least four specific 
                          subtypes of d&eacute;j&agrave; vu corresponding to diagnostic 
                          categories and that such phenomenological experiences 
                          may be used in diagnosis and management (N=89 ) **. 
                          89 subjects were grouped into 2 categories (normals 
                          with and without subjective paranormal experiences) 
                          and a neuropsychiatric group (with schizophrenics and 
                          temporal lobe epileptics and other epileptics) to test 
                          the hypothesis that there are several distinct clinical 
                          pictures of d&eacute;j&agrave; vu that are homogenous 
                          for diagnostic or nosological subtype. A <A HREF="../neuropsychiatry/instruments/deja_vu.html"> 
                          d&eacute;j&agrave; vu questionnaire</A> consisting of 
                          screening and qualitative questions as well as a less 
                          structured chosen-case description was used as a measuring 
                          instrument to retrospectively evaluate Ss' d&eacute;j&agrave; 
                          vu experiences. Four distinct clinically homogeneous 
                          categories of the d&eacute;j&agrave; vu experience emerged 
                          using multidimensional scaling and in fact they were 
                          distributed in four different quadrants in the median 
                          column geometry analysis. In the Normals: Subjective 
                          paranormal d&eacute;j&agrave; vu experience was characterized 
                          by its time distortions and specific predictions component 
                          occurred in the subjective paranormal experiment. In 
                          the average person, normals without claimed psychic 
                          experience, the experience of d&eacute;j&agrave; vu 
                          had a lack of memorable/outstanding features, just a 
                          perplexity and is generally infrequent and short lasting 
                          - so called, <I>Associative D&eacute;j&agrave; Vu</I>. 
                          In the neuropsychiatric group, d&eacute;j&agrave; vu 
                          experienced by temporal lobe epileptics was characterized 
                          by ictal and postepileptic features, such as stereotypical 
                          other temporal lobe features with headache, clouded 
                          consciousness and sleepiness afterwards. This type of 
                          experience did not occur in schizophrenics, whose d&eacute;j&agrave; 
                          vu experiences were characterized by psychotic intrusions. 
                          The data support the empirical validation of the Neppe 
                          D&eacute;j&agrave; Vu Questionnaire, the first of its 
                          kind. Qualitative d&eacute;j&agrave; vu screening instrument 
                          for psychosis, seizures and subjective <A HREF="../research/anomalous/">anomalous 
                          experience</A> has possible valuable applications. This 
                          framework has enormous potential phenomenologic application 
                          to the detail needed in analyzing other neuropsychiatric 
                          experience. </P>
                        <A NAME="concept"></A> <H2>Concept of D&eacute;j&agrave; 
                          Vu:</H2>
                        <P> Neppe's empirically tested operational definition 
                          for d&eacute;j&agrave; vu is <I>any subjectively inappropriate 
                          impression of familiarity of the present experience 
                          with an undefined past.</I> A theoretical motivation 
                          for this definition involves reasons for the rejection 
                          of other terms, and d&eacute;j&agrave; vu is differentiated 
                          from flashbacks, pseudopresentiment, actualized precognition, 
                          and cryptomnesia. There are 21 kinds of d&eacute;j&agrave; 
                          vu, including 10 new terms introduced by the author. 
                          There is also a metaphorical journalistic use of the 
                          term. There are 7 major phenomenological classifications 
                          of the d&eacute;j&agrave; vu experience: a disorder 
                          of memory, a disorder of ego state, an ego defense, 
                          a temporal perceptual disturbance, a recognition disorder, 
                          a manifestation of epileptic firing, or a subjective 
                          paranormal experience. </P>
                        <A NAME="incidence"></A> <H2>Incidence of D&eacute;j&agrave; 
                          Vu:</H2>
                        <P> The incidence of the d&eacute;j&agrave; vu experience 
                          is dependent on the operational definitions of d&eacute;j&agrave; 
                          vu, the measuring instrument, and the recall and recognition 
                          of the d&eacute;j&agrave; vu experience by the subject. 
                          16 studies of d&eacute;j&agrave; vu existed by the early 
                          1980s, but the only one using adequate sampling were 
                          the 2 studies by Neppe which also used an adequate 
                          screening questionnaire for d&eacute;j&agrave; vu. A 
                          more adequate study of incidence should use a large, 
                          randomized sample for the general population in a prospective 
                          study of incidence and frequency in the individual. 
                          Overall, about 70% of the population seem to report 
                          d&eacute;j&agrave; vu. <A NAME="ages"></A> 
                        <H2>Ages of D&eacute;j&agrave; Vu:</H2>
                        <P> The youngest age of d&eacute;j&agrave; vu reported 
                          is age 5. (two cases in Neppe's samples; one aged 6 
                          reported by Ouspensky). This has major theoretical implications 
                          for cognitive development. There is a complex interchange 
                          with age and incidence based on quality of remembering. 
                          There was at one point the idea that there was an inverse 
                          relationship with age in adulthood but this is disputed 
                          in one study by Neppe in the elderly. </P>
                        <A NAME="causes"></A> <H2>Causes of D&eacute;j&agrave; 
                          Vu:</H2>
                        <P> There is no single theoretical cause of d&eacute;j&agrave; 
                          vu that can explain its wide variety of clinical manifestations. 
                          Most instances of associative d&eacute;j&agrave; vu 
                          are associated with a predisposing milieu of anxiety 
                          and are triggered by restricted paramnesia and redintegration. 
                          The Psychoanalytic and psychodynamic theories are also 
                          common explanations. However, temporal lobe firing and 
                          the double access theories account for many of the experimental 
                          and clinical features of the d&eacute;j&agrave; vu experience 
                          of temporal lobe epileptics. Also, several parapsychological 
                          hypotheses have been advanced. D&eacute;j&agrave; vu 
                          in schizophrenics reflects a further nosological category, 
                          again implying different etiologies, precipitators, 
                          and pathogeneses. </P>
                        <A NAME="is deja vu a symptom"></A> <H2>Is D&eacute;j&agrave; 
                          Vu a symptom of temporal lobe epilepsy?</H2>
                        <P> The definition and conceptualization of the d&eacute;j&agrave; 
                          phenomenon are interpreted in various ways in medicine. 
                          The common occurrence of d&eacute;j&agrave; is the general 
                          population stresses the need for the development of 
                          specific qualitative features for valuable diagnosis 
                          of temporal lobe epilepsy. Qualitatively this exists. 
                        </P>
                        <A NAME="references"></A> <H2> Neppe References on D&eacute;j&agrave; 
                          Vu pertaining to above: </H2>
                        <P> Please note these references are provided as a service; 
                          they cannot be sent to you. </P>
                        <OL>
                          <LI> Neppe VM: Is d&eacute;j&agrave; vu a symptom of 
                            temporal lobe epilepsy? S Afr Med J 1981; 60 (23): 
                            907-8. </LI>
                          <LI> Neppe VM: A study of d&eacute;j&agrave; vu experience: 
                            thesis. Johannesburg, University of the Witwatersrand, 
                            1981:1-1-588, Vol 1-4. 3. Neppe VM: A study of d&eacute;j&agrave; 
                            vu experience. 1982. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu and temporal lobe 
                            epilepsy. London, 1982:1-36. </LI>
                          <LI> Neppe VM: The Psychology of d&eacute;j&agrave; 
                            vu: Have I been Here Before?: 1-277 & I-XLV. Johannesburg, 
                            Witwatersrand University Press, 1983. </LI>
                          <LI> Neppe VM: The different presentations of the d&eacute;j&agrave; 
                            vu phenomenon: New research. 1983:1-124-139. </LI>
                          <LI> Neppe VM: The incidence of d&eacute;j&agrave; vu. 
                            Parapsychological Journal of South Africa 1983; 4 
                            (2): 94-106. </LI>
                          <LI> Neppe VM: The concept of d&eacute;j&agrave; vu. 
                            Parapsychological Journal of South Africa 1983; 4 
                            (1): 1-10. </LI>
                          <LI> Neppe VM: The causes of d&eacute;j&agrave; vu. 
                            Parapsychological Journal of South Africa 1983; 4 
                            (1): 25-35. </LI>
                          <LI> Neppe VM: Genes, genetics and heritability: Beyond 
                            semantics. 1983:1-84-85. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu: A parapsychological 
                            approach, in Roll WG, Beloff, J, White, RA (eds.) 
                            Research in Parapsychology 1982 Metuchen, NJ., Scarecrow 
                            Press, 1983, pp 226-228. </LI>
                          <LI> Neppe VM: Age and the frequency of d&eacute;j&agrave; 
                            vu. 1983:1-182-184. </LI>
                          <LI> Neppe VM: Temporal lobe, psi and d&eacute;j&agrave; 
                            vu. 1985:1-330. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu in the survival 
                            context. Theta 1986; 13/14 (2): 26-29. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu: phenomenological 
                            and diagnostic relevance in temporal lobe epilepsy. 
                            1986:1-608. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu:1. What is it? 
                            ASPR Newsl 1987; 13 (1): 6-7. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu: 2. When and how? 
                            ASPR Newsl 1987; 13 (2): 15-16. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu: 3. Why? ASPR Newsl 
                            1987; 13 (3): 24-25. </LI>
                          <LI> Neppe VM: d&eacute;j&agrave; vu: 4. The differences. 
                            ASPR Newsl 1987; 13 (4): 31-32. </LI>
                        </OL>
                        <h3 align="center">&nbsp;</h3>
                        <P align="right"><font face="Arial, Helvetica, sans-serif"><a href="#top"><img src="../top.gif" width="48" height="19" border="0"></a></font></P></td>
                    </tr>
                  </table>                  <p>&nbsp;</p>
<p>&nbsp;</p>
			    </td>
              </tr>
            </table>
            
          </td>
        </tr>
        <tr>
          <td height="29"><img src="../bottom.jpg" width="700" height="29" border="0" usemap="#Map3"></td>
        </tr>
      </table></td>
  </tr>
</table>
<p align="center"><br>
  <font size="2" face="Arial, Helvetica, sans-serif">Copyright &copy;1997-2018 
  Pacific Neuropsychiatric Institute</font><br>
</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<map name="Map3">
  <area shape="rect" coords="237,3,385,23" href="http://pni.org/about_pni.html">
  <area shape="rect" coords="410,5,566,25" href="http://www.pni.org/disclaimer.html">
  <area shape="rect" coords="582,3,682,26" href="http://www.pni.org/credits.html">
</map>
</body>
</html>
